Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats

Transplantation

Volumn 73, Issue 4, 2002, Pages 512-518

  Ikebukuro, Kazuya ^a   Adachi, Yasushi ^a   Yamada, Yuichiro ^a   Fujimoto, Shimpei ^a   Seino, Yutaka ^a   Oyaizu, Haruki ^a   Hioki, Koshiro ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; IRRADIATION; MALE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 0037181120     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202270-00004     Document Type: Article

References (37)

1. Prevention of type 1 diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation
2. Type-I diabetes: A chronic autoimmune disease of human, mouse, and rat
3. Pancreatic islet allograft function in nonimmunosuppressed conscious mice
4. Metabolic and morphologic studies in intraportal-islet-transplanted rats
5. Prolonged survival ofintraportal versus subrenal capsular transplanted islet allografts
6. A comparison of portal versus systemic venous drainage in murine foetal pancreatic islet transplantation
7. The evolution of function and response to arginine challenge and pregnancy of portally and systemically placed islet cell grafts in streptozotocin diabetic mice
8. Importance of hepatic portal circulation for insulin action in streptozotocin-diabetic rats transplanted with fetal pancreas
9. Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras
10. Actively acquired tolerance of foreign cells
11. Successful liver allografts in mice by combination with allogeneic bone marrow transplantation
12. Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue
13. Successful pancreatic allografts in combination with bone marrow transplantation in mice
14. Tolerance induction for islet transplantation
15. A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance
16. Kupffer cell blockade inhibits induction of tolerance by the portal venous route
17. Induction of donor-specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodies
18. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: Possible explanation for the mechanism of tolerance induction by portal vein injection
19. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells
20. A strategy for organ allografts without using immunosuppressants or irradiation
21. Acceptance of skin allografts in pigs by portal venous injection of donor bone marrow cells
22. Autoimmune diabetes induced by the β-cell toxin STZ
23. Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice
24. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation
25. A novel strategy for organ allografts using sublethal (7Gy) irradiation followed by injection of donor bone marrow cells via portal vein
26. Pancreatic islet xenotransplantation: The potential for tolerance induction
27. Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus
28. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts
29. Diagnosis, management, and outcome of late duodenal complications in portal-enteric pancreas transplantation
30. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo
31. Analyses of extrathymic T cell differentiation in nu/nu mice by grafting embryonal organs
32. - cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers
33. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice
34. Intra-bone marrow injection of allogeneic bone marrow cells: A powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice
35. Development of insulin-dependent diabetes mellitus in [(NOD + BALB/c) → NOD] mixed allogeneic bone marrow chimeras
36. Distinct qualitative differences between normal and abnormal hemopoietic stem cells in vivo and in vitro
37. Split tolerance in spleen chimeras